Divestiture

Accord Healthcare's launch of generic lenalidomide signals a new era of affordability for a key cancer drug, intensifying competition and lowering costs.

NexLiving sells a Quebec property at a premium and declares a dividend, showcasing a dual strategy of aggressive growth and steady shareholder returns.

Ahead of its March 3 earnings call, 908 Devices' strong preliminary results and focus on handheld tech signal a pivotal year for the security innovator.

New Commerce Dept. duties on Chinese graphite aim to reshape the U.S. battery industry, but will it secure the supply chain or just raise EV costs?

With a bolstered cash runway from recent funding, Inventiva is all-in on its MASH drug, lanifibranor, racing against giants in a multi-billion dollar market.

After a year of major acquisitions and divestitures, the packaging giant posts surging profits and outlines a simplified, focused strategy for 2026.

Armada Hoffler rebrands as AH Realty Trust, divesting multifamily and construction assets to slash debt and double down on the retail and office sectors.

Safe Bulkers sells a 14-year-old ship for $35.2M, capitalizing on a strong market to fund a new generation of eco-friendly vessels.

As state and federal cuts threaten vital services, Bloomington Health Foundation offers critical bridge funding to stabilize local nonprofits on the brink.

Disc Medicine's promising EPP drug hits a major roadblock as the FDA seeks more data, delaying hope for patients and setting up a high-stakes trial.

Facing a massive exodus of players and tax revenue to offshore sites, Finland is dismantling its state monopoly for a regulated online gambling market.

Las Vegas Sands names Patrick Dumont CEO, signaling a new chapter focused on executing massive multi-billion dollar investments in Macao and Singapore.

Jasmine Hartin is vindicated as drug and assault charges are dismissed, raising questions about a 'weaponized' legal system in her ongoing public saga.

The Canadian restaurant giant defied a tough market in 2025, posting record sales and boosting investor payouts through strategic promotions and delivery.

Tucows announced a new $40M stock buyback, but investor concerns over its strategic pivot and debt overshadow the move, pushing shares lower.

Vitalist reports soaring losses and a $6.4M debt surge, raising 'going concern' alarms. Can its new Reebok smartwatches and VitalOS™ platform save it?

With revolutionary tech and a volatile stock, PureCycle's year-end update is a critical test of its operational progress and financial promises.

The retail REIT reports record-breaking leasing and strong profits for 2025, while executing a strategic portfolio overhaul and setting a confident tone for 2026.

With federal Grad PLUS loans ending July 2026, a Massachusetts agency is expanding its programs to prevent a major funding crisis for students.

Eight students win $45,000 each in a prestigious award that pairs cash with critical mentorship, investing in the region's next generation of innovators.